Insider Trades51 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2025 | Sell | VOR | Tirtha Chakraborty | Chief Sci Off & Head Tech Ops | 876 | $0.56 | $1.3B | -55.36% | +243.08% | $490.56 | -0.40% | — | Buy Now |
| May 6, 2025 | Sell | VOR | Robert Ang | PRESIDENT AND CEO | 2,361 | $0.56 | $1.3B | -55.36% | +243.08% | $1.3K | -0.26% | — | Buy Now |
| May 1, 2025 | Sell | VOR | Tirtha Chakraborty | Chief Sci Off & Head Tech Ops | 1,947 | $0.66 | $1.3B | -55.36% | +243.08% | $1.3K | -0.44% | — | Buy Now |
| May 1, 2025 | Sell | VOR | Han Wook Choi | Chief Financial Officer | 2,061 | $0.66 | $1.3B | -55.36% | +243.08% | $1.4K | -3.86% | — | Buy Now |
| May 1, 2025 | Sell | VOR | Robert Ang | PRESIDENT AND CEO | 5,273 | $0.66 | $1.3B | -55.36% | +243.08% | $3.5K | -0.29% | — | Buy Now |
| Feb 13, 2025 | Sell | VOR | Eyal C. Attar | CHIEF MEDICAL OFFICER | 2,227 | $1.42 | $1.3B | -55.36% | +243.08% | $3.2K | -1.73% | 10b5-1 | Buy Now |
| Feb 10, 2025 | Sell | VOR | Eyal C. Attar | CHIEF MEDICAL OFFICER | 2,554 | $1.37 | $1.3B | -55.36% | +243.08% | $3.5K | -1.94% | 10b5-1 | Buy Now |
| Feb 6, 2025 | Sell | VOR | Tirtha Chakraborty | CHIEF SCIENTIFIC OFFICER | 1,033 | $1.50 | $1.3B | -55.36% | +243.08% | $1.5K | -0.47% | — | Buy Now |
| Feb 6, 2025 | Sell | VOR | Eyal C. Attar | CHIEF MEDICAL OFFICER | 1,180 | $1.50 | $1.3B | -55.36% | +243.08% | $1.8K | -0.89% | — | Buy Now |
| Feb 6, 2025 | Sell | VOR | Robert Ang | PRESIDENT AND CEO | 2,787 | $1.50 | $1.3B | -55.36% | +243.08% | $4.2K | -0.30% | — | Buy Now |
| Feb 3, 2025 | Sell | VOR | Tirtha Chakraborty | CHIEF SCIENTIFIC OFFICER | 1,163 | $1.34 | $1.3B | -55.36% | +243.08% | $1.6K | -0.10% | — | Buy Now |
| Feb 3, 2025 | Sell | VOR | Eyal C. Attar | CHIEF MEDICAL OFFICER | 1,353 | $1.34 | $1.3B | -55.36% | +243.08% | $1.8K | -0.14% | — | Buy Now |
| Feb 3, 2025 | Sell | VOR | Robert Ang | PRESIDENT AND CEO | 3,248 | $1.34 | $1.3B | -55.36% | +243.08% | $4.4K | -0.09% | — | Buy Now |
| Dec 27, 2024 | Sell | VOR | Eyal C. Attar | CHIEF MEDICAL OFFICER | 10,334 | $1.25 | $1.3B | -55.36% | +243.08% | $12.9K | -11.26% | 10b5-1 | Buy Now |
| Nov 6, 2024 | Sell | VOR | Amy Quinlan | Vice President of Finance | 206 | $0.86 | $1.3B | -55.36% | +243.08% | $177.16 | -0.41% | — | Buy Now |
| Nov 6, 2024 | Sell | VOR | Tirtha Chakraborty | CHIEF SCIENTIFIC OFFICER | 875 | $0.86 | $1.3B | -55.36% | +243.08% | $752.5 | -0.51% | — | Buy Now |
| Nov 6, 2024 | Sell | VOR | Eyal C. Attar | CHIEF MEDICAL OFFICER | 999 | $0.86 | $1.3B | -55.36% | +243.08% | $859.14 | -1.08% | — | Buy Now |
| Nov 6, 2024 | Sell | VOR | Robert Ang | PRESIDENT AND CEO | 2,361 | $0.86 | $1.3B | -55.36% | +243.08% | $2.0K | -0.30% | — | Buy Now |
| Nov 1, 2024 | Sell | VOR | Amy Quinlan | Vice President of Finance | 343 | $0.80 | $1.3B | -55.36% | +243.08% | $274.4 | -0.67% | — | Buy Now |
| Nov 1, 2024 | Sell | VOR | Tirtha Chakraborty | CHIEF SCIENTIFIC OFFICER | 986 | $0.80 | $1.3B | -55.36% | +243.08% | $788.8 | -0.57% | — | Buy Now |
| Nov 1, 2024 | Sell | VOR | Eyal C. Attar | CHIEF MEDICAL OFFICER | 1,146 | $0.80 | $1.3B | -55.36% | +243.08% | $916.8 | -1.22% | — | Buy Now |
| Nov 1, 2024 | Sell | VOR | Robert Ang | PRESIDENT AND CEO | 2,751 | $0.80 | $1.3B | -55.36% | +243.08% | $2.2K | -0.35% | — | Buy Now |
| Sep 3, 2024 | Sell | VOR | Tirtha Chakraborty | CHIEF SCIENTIFIC OFFICER | 5,576 | $0.83 | $1.3B | -55.36% | +243.08% | $4.6K | -3.14% | — | Buy Now |
| Sep 3, 2024 | Sell | VOR | Robert Ang | PRESIDENT AND CEO | 12,657 | $0.83 | $1.3B | -55.36% | +243.08% | $10.5K | -1.57% | — | Buy Now |
| Aug 6, 2024 | Sell | VOR | Tirtha Chakraborty | CHIEF SCIENTIFIC OFFICER | 876 | $0.87 | $1.3B | -55.36% | +243.08% | $762.12 | -0.49% | — | Buy Now |
| Aug 6, 2024 | Sell | VOR | Eyal C. Attar | CHIEF MEDICAL OFFICER | 999 | $0.87 | $1.3B | -55.36% | +243.08% | $869.13 | -1.05% | — | Buy Now |
| Aug 6, 2024 | Sell | VOR | Robert Ang | PRESIDENT AND CEO | 2,361 | $0.87 | $1.3B | -55.36% | +243.08% | $2.1K | -0.29% | — | Buy Now |
| Aug 1, 2024 | Sell | VOR | Tirtha Chakraborty | CHIEF SCIENTIFIC OFFICER | 985 | $0.94 | $1.3B | -55.36% | +243.08% | $925.9 | -0.55% | — | Buy Now |
| Aug 1, 2024 | Sell | VOR | Eyal C. Attar | CHIEF MEDICAL OFFICER | 1,146 | $0.94 | $1.3B | -55.36% | +243.08% | $1.1K | -1.19% | — | Buy Now |
| Aug 1, 2024 | Sell | VOR | Robert Ang | PRESIDENT AND CEO | 2,751 | $0.94 | $1.3B | -55.36% | +243.08% | $2.6K | -0.34% | — | Buy Now |
| Aug 1, 2024 | Sell | VOR | Amy Quinlan | Vice President of Finance | 4,951 | $0.84 | $1.3B | -55.36% | +243.08% | $4.2K | -2.97% | — | Buy Now |
| Jun 3, 2024 | Sell | VOR | Eyal C. Attar | CHIEF MEDICAL OFFICER | 14,645 | $1.39 | $1.3B | -55.36% | +243.08% | $20.4K | -13.23% | 10b5-1 | Buy Now |
| May 6, 2024 | Sell | VOR | Nathan D. Jorgensen | CHIEF FINANCIAL OFFICER | 834 | $1.75 | $1.3B | -55.36% | +243.08% | $1.5K | -0.44% | — | Buy Now |
| May 6, 2024 | Sell | VOR | Tirtha Chakraborty | CHIEF SCIENTIFIC OFFICER | 875 | $1.75 | $1.3B | -55.36% | +243.08% | $1.5K | -0.49% | — | Buy Now |
| May 6, 2024 | Sell | VOR | Eyal C. Attar | CHIEF MEDICAL OFFICER | 999 | $1.75 | $1.3B | -55.36% | +243.08% | $1.7K | -0.89% | — | Buy Now |
| May 6, 2024 | Sell | VOR | Robert Ang | PRESIDENT AND CEO | 2,361 | $1.75 | $1.3B | -55.36% | +243.08% | $4.1K | -0.29% | — | Buy Now |
| May 1, 2024 | Sell | VOR | Nathan D. Jorgensen | CHIEF FINANCIAL OFFICER | 917 | $1.77 | $1.3B | -55.36% | +243.08% | $1.6K | -0.48% | — | Buy Now |
| May 1, 2024 | Sell | VOR | Tirtha Chakraborty | CHIEF SCIENTIFIC OFFICER | 985 | $1.77 | $1.3B | -55.36% | +243.08% | $1.7K | -0.54% | — | Buy Now |
| May 1, 2024 | Sell | VOR | Eyal C. Attar | CHIEF MEDICAL OFFICER | 1,146 | $1.77 | $1.3B | -55.36% | +243.08% | $2.0K | -1.02% | — | Buy Now |
| May 1, 2024 | Sell | VOR | Robert Ang | PRESIDENT AND CEO | 2,751 | $1.77 | $1.3B | -55.36% | +243.08% | $4.9K | -0.34% | — | Buy Now |
| Mar 1, 2024 | Sell | VOR | Tirtha Chakraborty | CHIEF SCIENTIFIC OFFICER | 5,576 | $2.27 | $1.3B | -55.36% | +243.08% | $12.7K | -2.99% | — | Buy Now |
| Mar 1, 2024 | Sell | VOR | Nathan D. Jorgensen | CHIEF FINANCIAL OFFICER | 6,310 | $2.27 | $1.3B | -55.36% | +243.08% | $14.3K | -3.20% | — | Buy Now |
| Mar 1, 2024 | Sell | VOR | Robert Ang | PRESIDENT AND CEO | 12,657 | $2.27 | $1.3B | -55.36% | +243.08% | $28.7K | -1.53% | — | Buy Now |
| Feb 6, 2024 | Sell | VOR | Nathan D. Jorgensen | CHIEF FINANCIAL OFFICER | 985 | $2.32 | $1.3B | -55.36% | +243.08% | $2.3K | -0.50% | — | Buy Now |
| Feb 6, 2024 | Sell | VOR | Tirtha Chakraborty | CHIEF SCIENTIFIC OFFICER | 1,033 | $2.32 | $1.3B | -55.36% | +243.08% | $2.4K | -0.55% | — | Buy Now |
| Feb 6, 2024 | Sell | VOR | Eyal C. Attar | CHIEF MEDICAL OFFICER | 1,180 | $2.32 | $1.3B | -55.36% | +243.08% | $2.7K | -1.03% | — | Buy Now |
| Feb 6, 2024 | Sell | VOR | Robert Ang | PRESIDENT AND CEO | 2,788 | $2.32 | $1.3B | -55.36% | +243.08% | $6.5K | -0.34% | — | Buy Now |
| Nov 6, 2023 | Sell | VOR | Nathan D. Jorgensen | Chief Financial Officer | 834 | $1.82 | $1.3B | -55.36% | +243.08% | $1.5K | -0.57% | — | Buy Now |
| Nov 6, 2023 | Sell | VOR | Tirtha Chakraborty | Chief Scientific Officer | 876 | $1.82 | $1.3B | -55.36% | +243.08% | $1.6K | -0.65% | — | Buy Now |
| Nov 6, 2023 | Sell | VOR | Eyal C. Attar | Chief Medical Officer | 999 | $1.82 | $1.3B | -55.36% | +243.08% | $1.8K | -1.90% | — | Buy Now |
| Nov 6, 2023 | Sell | VOR | Robert Ang | President and CEO | 2,361 | $1.82 | $1.3B | -55.36% | +243.08% | $4.3K | -0.35% | — | Buy Now |